Sandbox/v31: Difference between revisions
< Sandbox
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
__NOEDITSECTION____NOTOC__ | __NOEDITSECTION____NOTOC__ | ||
{{Meningitis}} | {{Meningitis}} | ||
Line 21: | Line 22: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Newborn, Age <1 Week}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 44: | Line 45: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Newborn, Age 1—4 Weeks}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 67: | Line 68: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Infant & Children}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 83: | Line 84: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Adult, Age <50 Years}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 101: | Line 102: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Adult, Age >50 Years}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 121: | Line 122: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Immunocompromised}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 141: | Line 142: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Recurrent}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 164: | Line 165: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Basilar Skull Fracture}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 179: | Line 180: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Head Trauma; Post-Neurosurgery}} | ||
|-! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | |-! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
|- | |- |
Revision as of 04:43, 20 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Sheng Shi, M.D. [3]
Empiric Therapy Adapted from Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693-702.[1]
Community-Acquired Meningitis ▸ Newborn, Age <1 Week
▸ Newborn, Age 1—4 Weeks
▸ Infant & Children
▸ Adult, Age <50 Years
▸ Adult, Age >50 Years
▸ Immunocompromised
▸ Recurrent
|
|
Healthcare-Associated Meningitis ▸ Basilar Skull Fracture
▸ Head Trauma; Post-Neurosurgery
|
|